XML 28 R20.htm IDEA: XBRL DOCUMENT v3.23.3
NET LOSS PER SHARE OF COMMON STOCK
 5 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
NET LOSS PER SHARE OF COMMON STOCK

NOTE 13. NET LOSS PER SHARE OF COMMON STOCK

 

Basic and diluted net loss per share is computed by dividing net loss attributable to stockholders by the weighted average number shares of common stock outstanding during the period and shares issuable for vested restricted stock units. Potentially dilutive outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share for loss periods presented because including them would have been antidilutive.

 

A reconciliation of the numerator and denominator used in the calculation of basic and diluted net loss per share attributable to stockholders follows:  

Reconciliation of diluted shares        
   Three Months Ended June 30, 
   2023   2022 
Numerator:        
Net (loss) allocable to common stockholders used to compute basic and diluted loss per common share  $(1,464,557)  $(3,683,070)
Denominator:          
Weighted average shares outstanding used to compute basic and dilutive loss per share   8,087,755    – 
Weighted average shares issuable for vested restricted stock units   199,914    – 
Total weighted average shares diluted   8,287,669    7,821,515 

 

         
   Six Months Ended June 30, 
   2023   2022 
Numerator:          
Net (loss) allocable to common stockholders used to compute basic and diluted loss per common share  $(2,648,017)  $(4,906,473)
Denominator:          
Weighted average shares outstanding used to compute basic and dilutive loss per share   7,974,635    4,373,668 
Weighted average shares issuable for vested restricted stock units   145,347    – 
Total weighted average shares diluted   8,119,982    4,373,668 

 

 

The following outstanding potentially dilutive securities were excluded from the weighted average calculation of dilutive loss per share attributable to common stockholders because their impact would have been antidilutive for the period presented: 

         
  

June 30,

2023

  

June 30,

2022

 
         
Series A and B convertible preferred stock   –    1,639,559 
Warrants   3,518,550    1,570,236 
Restricted stock units   692,422    – 
Stock options   2,738,820    2,351,510 
    6,949,792    5,561,305